ANNUAL REPORT

Company

Compass Therapeutics, Inc.

Filed

June 8, 2020

Period of Report

March 31, 2020

Accession Number

0001213900-20-014390

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →